×
Concentras Parent Net Profit Margin 2022-2024 | CON
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Concentras Parent net profit margin from 2022 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
View More
Concentras Parent Net Profit Margin 2022-2024 | CON
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Concentras Parent net profit margin from 2022 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
Related Stocks
Company Name
Market
Cap
Elevance Health (ELV)
$99.6B
Cencora (COR)
$48.8B
DiDi Global (DIDIY)
$24.4B
ICON (ICLR)
$17.7B
Natera (NTRA)
$16.1B
Viatris (VTRS)
$15.7B
Avantor (AVTR)
$15.6B
Revvity (RVTY)
$15.1B
BioMerieux (BMXMF)
$13.1B
Solventum (SOLV)
$13B
CochLear (CHEOY)
$12.8B
Medpace Holdings (MEDP)
$11B
Charles River Laboratories (CRL)
$10.8B
Sonic Healthcare (SKHHY)
$8.8B
HealthEquity (HQY)
$8.5B
Doximity (DOCS)
$8.1B
Bausch + Lomb (BLCO)
$7.1B
Life Times (LTH)
$5.1B
Sotera Health (SHC)
$4.5B
Organon (OGN)
$4.2B
Surgery Partners (SGRY)
$3.9B
BrightSpring Health Services (BTSG)
$3.3B
PACS (PACS)
$3B
Alignment Healthcare (ALHC)
$2.6B
Ardent Health Partners (ARDT)
$2.5B
Premier (PINC)
$2.3B
GeneDx Holdings (WGS)
$2.1B
Ryman Healthcare (RYHTY)
$2B
GoodRx Holdings (GDRX)
$1.9B
Teladoc Health (TDOC)
$1.6B